Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
VigorBiotics is a biotechnology and health-focused company specializing in the development and commercialization of advanced probiotic formulations and live biotherapeutic products. The company focuses on leveraging the gut microbiome to improve human health across various indications, including gastrointestinal wellness and immune system modulation. Their product line typically includes high-potency microbial strains designed for specific therapeutic outcomes. VigorBiotics aims to bridge the gap between traditional supplements and clinical-grade microbial therapies through rigorous strain selection and stabilization technologies. The company serves both the consumer health market and clinical research sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on VigorBiotics.